KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Non-Current Receivables (2016)

Historic Non-Current Receivables for Travere Therapeutics (TVTX) over the last 3 years, with Q2 2016 value amounting to $46.2 million.

  • Travere Therapeutics' Non-Current Receivables changed N/A to $46.2 million in Q2 2016 from the same period last year, while for Jun 2016 it was $46.2 million, marking a year-over-year change of. This contributed to the annual value of $45.6 million for FY2015, which is N/A changed from last year.
  • As of Q2 2016, Travere Therapeutics' Non-Current Receivables stood at $46.2 million.
  • Travere Therapeutics' Non-Current Receivables' 5-year high stood at $46.2 million during Q2 2016, with a 5-year trough of $137547.0 in Q1 2013.
  • In the last 3 years, Travere Therapeutics' Non-Current Receivables had a median value of $45.6 million in 2015 and averaged $36.6 million.